{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:01:01Z","timestamp":1792735261843,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13075-016-1094-y","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T12:29:09Z","timestamp":1472819349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial"],"prefix":"10.1186","volume":"18","author":[{"given":"George P.","family":"Karamanolis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stylianos","family":"Panopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Denaxas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Karlaftis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Zorbala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Kamberoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spiros D.","family":"Ladas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros P.","family":"Sfikakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,1]]},"reference":[{"key":"1094_CR1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","volume":"117","author":"J Varga","year":"2007","unstructured":"Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest. 2007;117:557\u201367.","journal-title":"J Clin Invest"},{"issue":"Suppl 29","key":"1094_CR2","first-page":"S15","volume":"21","author":"PJ Clements","year":"2003","unstructured":"Clements PJ, Becvar R, Drosos AA, Ghattas L, Gabrielli A. Assessment of gastrointestinal involvement. Clin Exp Rheumatol. 2003;21 Suppl 29:S15\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"1094_CR3","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/01.mcg.0000225549.19127.90","volume":"40","author":"EC Ebert","year":"2006","unstructured":"Ebert EC. Esophageal disease in scleroderma. J Clin Gastroenterol. 2006;40:769\u201375.","journal-title":"J Clin Gastroenterol"},{"key":"1094_CR4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.semarthrit.2006.08.002","volume":"36","author":"SK Ntoumazios","year":"2006","unstructured":"Ntoumazios SK, Voulgari PV, Potsis K, Koutis E, Tsifetaki N, Assimakopoulos DA. Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem. Semin Arthritis Rheum. 2006;36:173\u201381.","journal-title":"Semin Arthritis Rheum"},{"key":"1094_CR5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2036.2006.02804.x","volume":"23","author":"H Sallam","year":"2006","unstructured":"Sallam H, McNearney TA, Chen JD. Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma). Aliment Pharmacol Ther. 2006;23:691\u2013712.","journal-title":"Aliment Pharmacol Ther"},{"key":"1094_CR6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/2050640614560453","volume":"3","author":"G Karamanolis","year":"2015","unstructured":"Karamanolis G, Panopoulos S, Karlaftis A, Denaxas K, Kamberoglou D, Sfikakis PP, Ladas SD. Beneficial effect of the 5-HT1A receptor agonist buspirone on esophageal dysfunction associated with systemic sclerosis: a pilot study. United Eur Gastroenterol J. 2015;3:266\u201371.","journal-title":"United Eur Gastroenterol J"},{"key":"1094_CR7","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1111\/j.1365-2982.2011.01797.x","volume":"24","author":"C Hempfling","year":"2012","unstructured":"Hempfling C, Neuhuber WL, Worl J. Serotonin-immunoreactive neurons and mast cells in the mouse esophagus suggest involvement of serotonin in both motility control and neuroimmune interactions. Neurogastroenterol Motil. 2012;24:e67\u201378.","journal-title":"Neurogastroenterol Motil"},{"key":"1094_CR8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/MCG.0b013e318167b89d","volume":"43","author":"W Blonski","year":"2009","unstructured":"Blonski W, Vela MF, Freeman J, Sharma N, Castell DO. The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers. J Clin Gastroenterol. 2009;43:253\u201360.","journal-title":"J Clin Gastroenterol"},{"key":"1094_CR9","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1442-2050.2011.01275.x","volume":"25","author":"M Stefano Di","year":"2012","unstructured":"Di Stefano M, Papathanasopoulos A, Blondeau K, Vos R, Boecxstaens V, Farr\u00e9 R, et al. Effect of buspirone, a 5-HT1A receptor agonist, on esophageal motility in healthy volunteers. Dis Esophagus. 2012;25:470\u20136.","journal-title":"Dis Esophagus"},{"issue":"11","key":"1094_CR10","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F Hoogen van den","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747\u201355.","journal-title":"Ann Rheum Dis"},{"key":"1094_CR11","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1053\/j.gastro.2005.08.020","volume":"129","author":"B Geeraerts","year":"2005","unstructured":"Geeraerts B, Vandenberghe J, Van Oudenhove L, Gregory LJ, Aziz Q, Dupont P, et al. Influence of experimentally induced anxiety on gastric sensorimotor function in humans. Gastroenterology. 2005;129:1437\u201344.","journal-title":"Gastroenterology"},{"key":"1094_CR12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/nmo.12221","volume":"26","author":"N Bortoli de","year":"2014","unstructured":"de Bortoli N, Martinucci I, Savarino E, Bellini M, Bredenoord AJ, Franchi R, et al. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? Neurogastroenterol Motil. 2014;26:28\u201335.","journal-title":"Neurogastroenterol Motil"},{"key":"1094_CR13","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1259\/bjr\/17000205","volume":"79","author":"EH Pitrez","year":"2006","unstructured":"Pitrez EH, Bredemeier M, Xavier RM, Capobianco KG, Restelli VG, Vieira MV, et al. Oesophageal dysmotility in systemic sclerosis: comparison of HRTC and scintigraphy. Br J Radiol. 2006;79:719\u201324.","journal-title":"Br J Radiol"},{"issue":"Suppl 1","key":"1094_CR14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2982.2011.01834.x","volume":"24","author":"AJ Breedenoord","year":"2012","unstructured":"Breedenoord AJ, Fox M, Kahrilas PJ, Pandolfino JE, Schwizer W, Smout AJ, International High Resolution Manometry Working Group. Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil. 2012;24 Suppl 1:57\u201365.","journal-title":"Neurogastroenterol Motil"},{"key":"1094_CR15","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1365-2982.2009.01314.x","volume":"21","author":"F Gao","year":"2009","unstructured":"Gao F, Liao D, Drewes AM, Gregersen H. Modelling the elastin, collagen and smooth muscle contribution to the duodenal mechanical behaviour in patients with systemic sclerosis. Neurogastroenterol Motil. 2009;21:914\u2013e68.","journal-title":"Neurogastroenterol Motil"},{"key":"1094_CR16","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1365-2982.2009.01350.x","volume":"21","author":"TA McNearney","year":"2009","unstructured":"McNearney TA, Sallam HS, Hunnicutt SE, Doshi D, Wollaston DE, Mayes MD, Chen J. Gastric slow waves, gastrointestinal symptoms and peptides in systemic sclerosis patients. Neurogastroenterol Motil. 2009;21:1269\u2013e120.","journal-title":"Neurogastroenterol Motil"},{"key":"1094_CR17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainres.2012.04.032","volume":"1461","author":"C Loane","year":"2012","unstructured":"Loane C, Politis M. Buspirone: what is it all about? Brain Res. 2012;1461:111\u20138.","journal-title":"Brain Res"},{"key":"1094_CR18","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/ard.2007.081612","volume":"67","author":"MC Vonk","year":"2008","unstructured":"Vonk MC, Van Die CEV, Snoeren MM, Bhansing KJ, van Riel PL, Fransen J, van den Hoogen FH. Oesophageal dilatation on high-resolution computed tomography scan of the lungs as a sign of scleroderma. Ann Rheum Dis. 2008;67:1317\u201321.","journal-title":"Ann Rheum Dis"},{"key":"1094_CR19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1754-9485.2011.02317.x","volume":"55","author":"AK Pandey","year":"2011","unstructured":"Pandey AK, Wilcox P, Mayo JR, Moss R, Ellis J, Brown J, et al. Oesophageal dilatation on high-resolution CT chest in systemic sclerosis: What does it signify? J Med Imag Radiat Oncol. 2011;55:551\u20135.","journal-title":"J Med Imag Radiat Oncol"},{"key":"1094_CR20","doi-asserted-by":"crossref","first-page":"e90484","DOI":"10.1371\/journal.pone.0090484","volume":"9","author":"C Nguyen","year":"2014","unstructured":"Nguyen C, Ranque B, Baubet T, B\u00e9rezn\u00e9 A, Mestre-Stanislas C, Rannou F, et al. Clinical, functional and health-related quality of life correlates of clinically significant symptoms of anxiety and depression in patients with systemic sclerosis: a cross-sectional survey. PLoS One. 2014;9:e90484.","journal-title":"PLoS One"},{"key":"1094_CR21","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.bor.0000434666.47397.c2","volume":"25","author":"VL Malcarne","year":"2013","unstructured":"Malcarne VL, Fox RS, Mills SD, Gholizadeh S. Psychosocial aspects of systemic sclerosis. Curr Opin Rheumatol. 2013;25:707\u201313.","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"1094_CR22","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/art.24730","volume":"61","author":"D Khanna","year":"2009","unstructured":"Khanna D, Hays RD, Maranian P, Seibold JR, Impens A, Mayes MD, et al. Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. Arthritis Rheum. 2009;61(9):1257\u201363.","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-016-1094-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:53:39Z","timestamp":1498326819000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-016-1094-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1094"],"URL":"https:\/\/doi.org\/10.1186\/s13075-016-1094-y","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,1]]},"article-number":"195"}}